Physician profile
Tina Chaalan
NPI 1477916427
$5,011.49
in general payments reported to CMS, 2019-2025
38 companies · $915 in 2025
The $915 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $164 · 2021: $1,091 · 2022: $1,013 · 2023: $981 · 2024: $847 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,743.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $804.84 | 2020-2025 | Lo Loestrin Fe, Orilissa, Liletta |
| Aspira Women'S Health INC | $484.76 | 2021-2023 | Ova1 |
| Sumitomo Pharma America, INC. | $420.33 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $343.79 | 2021-2022 | |
| Organon LLC | $302.65 | 2021-2025 | Nexplanon, Nuvaring |
| Pfizer INC. | $265.78 | 2022-2024 | |
| Hologic Sales and Service, LLC | $258.85 | 2022-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $238.05 | 2020-2024 | Xifaxan |
| Exeltis, USA INC. | $215.86 | 2020-2025 | Slynd |
| Novo Nordisk INC | $186.28 | 2024-2025 | Wegovy |
| Mayne Pharma Commercial LLC | $179.52 | 2021-2025 | |
| Astellas Pharma US INC | $136.12 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $114.76 | 2020-2025 | |
| Lilly USA, LLC | $110.36 | 2025 | Zepbound |
| Agile Therapeutics, INC. | $108.36 | 2021-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $85.11 | 2021-2022 | |
| Exact Sciences Corporation | $79.20 | 2023-2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $67.30 | 2022-2025 | Injectafer |
| Coopersurgical, INC. | $63.14 | 2022-2025 | Paragard T 380a |
| Amgen INC. | $58.64 | 2021-2024 | Prolia, Evenity |
| Therapeuticsmd, INC. | $57.29 | 2022 | |
| Merck Sharp & Dohme LLC | $51.29 | 2021-2024 | Gardasil 9, Gardasil |
| Millicent US INC | $49.95 | 2024-2025 | Intrarosa, Femring |
| Seqirus USA INC | $39.31 | 2024-2025 | Flucelvax, Fluad |
| Meditrina | $35.53 | 2023-2024 | |
| Mylan Pharmaceuticals INC. | $31.91 | 2021-2022 | |
| Avion Pharmaceuticals | $27.67 | 2021-2023 | Balcoltra |
| Dexcom, INC. | $26.14 | 2024 | Dexcom G6 Transmitter |
| Sage Therapeutics, LLC | $25.64 | 2025 | Zurzuvae |
| Smith+Nephew, INC. | $24.68 | 2023 | Stravix Pl |
| Medicem INC. | $15.97 | 2023 | |
| Channel Medsystems, INC. | $15.93 | 2023 | |
| Ethicon US, LLC | $15.90 | 2025 | Vistaseal, Dermabond |
| Pacira Pharmaceuticals Incorporated | $15.88 | 2023 | Exparel |
| Dysis Medical, INC. | $15.12 | 2020 | |
| Medtronic, INC. | $14.91 | 2023 | Ligasure |
| Kci USA, INC. | $13.16 | 2023 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Minerva Surgical, INC | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Chaalan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.